Become a Member

Track your favourite stocks
Create & monitor portfolios
Daily portfolio value

Company	Chg	Chg %
Quickpicks
£	%
Add shares to your quickpicks to display them here!

TILS.L (TILS) Share News

Tiziana Life Sciences Submits Application For Foralumab Trial In US

20th Mar 2019 13:01

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday said it has submitted an application in the US to begin a phase one trial of its autoimmune and inflammatory disease drug new drug a Read More

Tiziana Life Sciences Non-Exec Director Riccardo Dalla-Favera Resigns

7th Feb 2019 11:40

LONDON (Alliance News) - Tiziana Life Sciences PLC on Thursday said Non-Executive Director Riccardo Dalla-Favera has resigned from his role."The company is grateful to Favera for his Read More

Tiziana Life Completes Patient Enrollment In Liver Cancer Trial

3rd Dec 2018 11:51

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday said it completed patient enrollment in a Phase 2a trial of Milciclib in hepatocellular carcinoma.The company explained that the Read More

Tiziana Life Sciences Begins First-In-Human Phase 1 Trial Of Foralumab

28th Nov 2018 12:19

LONDON (Alliance News) - Tiziana Life Sciences PLC on Wednesday said it began the first in-human trial of Foralumab, a treatment for autoimmune diseases.The biotechnology company said the a Read More

Tiziana Life Sciences Prices ADS Offering, Raises GBP3.4 Million

20th Nov 2018 12:53

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has priced its underwritten public offering in the US of 442,910 American Depositary Shares representing ordinary shares in Read More

Tiziana Life Seeks Listing Of ADS On Nasdaq Capital Market (ALLIPO)

25th Sep 2018 13:43

LONDON (Alliance News) - Tiziana Life Sciences PLC said Tuesday that it has commenced underwritten public offering in the US of American Depositary Shares representing ordinary shares in the UK of Read More

Tiziana Half-Year Loss Unchanged; Gets US Approval For Foralumab Trial

24th Sep 2018 12:37

LONDON (Alliance News) - Tiziana Life Sciences PLC on Monday reported a flat loss in the first half of 2018 as expenses were broadly unchanged, while the biotechnology firm also announced that its Read More

DIRECTOR DEALINGS: Tiziana Life Chairman Associate Buys Shares

17th Aug 2018 11:39

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday that Panetta Partners Ltd, a company associated with Chairman Gabriele Cerrone, bought shares in the company worth acquired 469,766 a Read More

Tiziana Life Sciences Files For IPO Of American Depositary Shares (ALLIPO)

27th Jul 2018 11:14

LONDON (Alliance News) - Tiziana Life Sciences PLC said Friday it filed a registration statement with the US Securities Exchange Commission for a proposed initial public offering of its American Read More

Tiziana Life Science Reports Progress In Milcicib Phase 2a Trial

16th May 2018 13:27

LONDON (Alliance News) - Biotechnology company Tiziana Life Sciences PLC said Wednesday that the phase 2a trial of Milciclib safety and tolerability in patients with Metastatic Hepatocellular has Read More

Tiziana Raises GBP825,000 Through Placing Of 1 Million Shares (ALLISS)

19th Apr 2018 14:44

LONDON (Alliance News) - Tiziana Life Sciences PLC said Thursday it has raised GBP825,000 from the issue of 1.0 million new shares at a price of 80 pence per share.The cancer and autoimmune Read More

Tiziana Appoints Leopoldo Zambeletti As Non-Executive Director

4th Apr 2018 12:53

LONDON (Alliance News) - Tiziana Life Sciences PLC, a biotechnology company developing drugs for cancer and autoimmune diseases, said Wednesday Leopoldo Zambeletti has joined Read More